• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Govt funds dry up to honour Indian scientists
  • Elsevier ranked Prof Ashok Pandey among top 5 scientists of India
  • A tribute to Father of Indian Green Revolution Dr M S Swaminathan
  • The Lancet was made for political activism- For 200 years, it has thrived on melodrama and scandal
  • Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology
  • FABA and ABF Conduct Hands-on Training on CRISPR-Cas-Mediated Genome Editing in Plants
  • US FDA grants Orphan Drug Designation for CRO-67
  • Integrative Medicines (IM) Market to Grow with a High CAGR during 2023-2035; Increasing Adoption of Natural Remedies Around the World to Drive Market Growth
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    May 22, 2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Interviews»Interviews - Industry»Prominent Virologist Prof. Guntaka V Ramareddy joins Advisory Board of Biotech Express
Prof Guntaka Ramareddy (right) with Dr APJ Abdul Kalam (left)

Prominent Virologist Prof. Guntaka V Ramareddy joins Advisory Board of Biotech Express

0
By Biotech Express on June 14, 2021 Interviews - Industry

Prof Guntaka was first scientist who introduced recombinant biotech drugs in India by making Hep-B  vaccine for Shantha biotech company in 1990s. Now he is running his company Sudarshan Biotech and is involved in the discovery of Hep-C vaccine which is not available anywhere in the world.

It is a privilege to have Dr. Ramareddy in the Advisory Board of Biotech Express magazine. Biotech Express welcome Prof Guntaka on its editorial board and we believe his accord will be much useful in current viral pandemic times.

Prof Ramareddy V Guntaka
Current Affiliations: Chairman and Chief Scientist, Sudarshan Biotech Pvt Ltd., TSIIC Park, Nacharam, Hyderabad, India & Emeritus Professor, Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee, USA

Dr. Ramareddy’s research background is in the field of Microbiology and he is an outstanding vaccine researcher who was the chief scientific resource in the success of India’s first biotechnology company i.e. Shantha Biotech.

He earned his Ph.D in Microbiology from Kansas State University, Manhattan in (1970). He was graduated with B.Sc in Chemistry and Biology, A.N.R. College, Gudivada, India and got his M.Sc in Microbiology from U.P. Agricultural University, Pantnagar, U.P., India (1965).

To use his expertise in the field of virology which is utmost importance in this current pandemic, we decided to invite him as an advisory member of board which Prof Guntaka has agreed to join. To give more  information to readers about his thinking process we posed some questions to get his vision and mission. These can be framed as following:

Q1. Sir how are you planning to contribute to this magazine?
Through Biotech Express we can provide information to the public on various issues related to health, state of the art developments in science and Technology etc. Up to date information on the COVID pandemic and the efficacy of various available vaccines which is vital for the citizens of India.

Q2. Sir what are your prime focus now after Hep-B?
Our primary focus is to bring vaccine for Hepatitis C and bring high value therapeutics at an affordable price. Many antigens used in the diagnostic kits are not made in India; most of these are currently imported. We already have several of them at Sudarshan Biotech and now we can market them.

Q3. Sir, what are your suggestions to scientific community which is involved in this current COVID-19 pandemic?
COVID-19 pandemic is an unusual disease. As everybody is aware, it is affecting all the age groups, although more devastating to the elderly and people with pre-existing health conditions. As an scientist we may look at vaccines and drugs that are more safe and efficient, healthcare workers may use more precautions to get away from infection and govt. may use data statistics to make more robust guidelines. For example, I have discussed earlier through this magazine that how we can avoid lockdowns which is subsequently affecting huge population and leading to unemployment and sufferings.

Q. What is your company Sudarshan biotech is manufacturing and what are future goals of this biotech company now?
Until recently Sudershan Biotech was located in a residential area and we are not allowed to manufacture any biotech products. Now we have relocated to Nacharam where we can manufacture. Sudershan Biotech is a Research oriented company and we have several patents including Hepatitis C virus sequence, Human Serum Albumin in Pichia pastoris, therapeutics like Interferon beta1a and 1b in E. coli. Soon we will start producing these and start clinical trials. We will also produce antigens for Hepatitis B and Hepatitis C viruses as well as Human Immunodeficiency virus.

Prof Guntaka Ramareddy has received many honors and awards like Government of India Merit Scholarship, 1963-1965; American Cancer Society Senior Dernham Fellowship, 1973-1975; Research Career Development Award from National Institutes of Health 1979-1984 and many others.

He has been appointed in various positions like Associate Professor, Department of Microbiology, School of Medicine, University of Missouri, Columbia; Assistant Professor, Department of Microbiology, College of Physicians and Surgeons, Columbia University; Assistant Research Microbiologist, University of CaIifornia, San Francisco. In his research career he has published over 110 research papers in reputed journals including Nature and also holds a patent.

Among the discovery of Hep B vaccine his other outstanding pioneer contributions are:
1. First group (with Bishop and Varmus) to show that retrovirus DNA replication occurs in the cytoplasm and then in the nucleus of infected cells and to show accumulation of supercoiled DNA in the nuclei of retrovirus-infected cells.
3 First group (Shank, Bishop, Varmus; Taylor) to demonstrate the presence of Long Terminal Repeats (LTRs) at the ends of retroviral DNA.
4. First group (with Stehelin, Bishop, Varmus) to discover proto-oncogenes.
5. First one to clone an infectious Rous sarcoma virus DNA (Walter Gilbert’ group sequenced this clone).
6. First to show methylation of provirus in non-permissive cells.
7. Demonstrated formation of triplexes of Triplex-forming oligonucleotide with the collagen gene promoter (resulted in a patent assignment to Guntaka).
8. First group to sequence the Indian strain of Hepatitis C Virus.

Last Updated on June 20, 2021

 

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

Interview: How to approach COVID-19 as biopreneur? Talk with Dr Ram S Upadhayaya

Interview – Women Achievers in Biotechnology – Dr. Poonam Sharma, Director, Gyan Bindu Academy Pvt. Ltd.

Leave A Reply Cancel Reply

Current Issue – October 2023
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Govt funds dry up to honour Indian scientists October 23, 2023
  • Elsevier ranked Prof Ashok Pandey among top 5 scientists of India October 22, 2023
  • A tribute to Father of Indian Green Revolution Dr M S Swaminathan October 21, 2023
  • The Lancet was made for political activism- For 200 years, it has thrived on melodrama and scandal October 15, 2023
  • Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology October 12, 2023
  • FABA and ABF Conduct Hands-on Training on CRISPR-Cas-Mediated Genome Editing in Plants October 12, 2023
  • US FDA grants Orphan Drug Designation for CRO-67 October 10, 2023
  • Integrative Medicines (IM) Market to Grow with a High CAGR during 2023-2035; Increasing Adoption of Natural Remedies Around the World to Drive Market Growth October 5, 2023
  • Scientists create human embryo in lab without eggs, sperm September 23, 2023
  • Concord Biotech: Stock Market’s New Biotech entrant ready with IPO July 31, 2023
  • National Research Foundation (NRF): facing support and resistance from scientific communities! Why? July 25, 2023
  • Biodiversity- preserve or perish July 24, 2023
  • Dr Rajesh Gokhale assumes charge as Secretary of Department of Science and Technology July 23, 2023
  • Advancing allergy detection and management in India: A pathway to improved health July 23, 2023
  • Gujarat govt signs MOUs with 15 companies for ₹2000 cr in a single day July 22, 2023
  • Pune biotech firm announces cheaper drug for colorectal cancer July 21, 2023
  • Ambiq Propels Remote Healthcare Monitoring Sector Growth with New Ultra-Low Processors July 20, 2023
  • BMJ Open retracted a diabetes paper because it was funded by tobacco company July 19, 2023
  • Indian scientist made First Marwari horse foal through Embryo transfer technology July 12, 2023
  • Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society May 22, 2023
  • FABA holds Conference on Antimicrobial Resistance Stewardship Series May 22, 2023
  • COVID no longer a global health emergency, WHO says May 18, 2023
  • Chemist in India loses seven papers of biology, blames outsourcing of images May 17, 2023
  • Indian Research scholars express frustration over DST’s tweet, plan stir May 16, 2023
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.